Cargando…
Expanding and improving nanobody repertoires using a yeast display method: Targeting SARS-CoV-2
COVID-19, caused by the coronavirus SARS-CoV-2, represents a serious worldwide health issue, with continually emerging new variants challenging current therapeutics. One promising alternate therapeutic avenue is represented by nanobodies, small single-chain antibodies derived from camelids with nume...
Autores principales: | Cross, Frederick R., Fridy, Peter C., Ketaren, Natalia E., Mast, Fred D., Li, Song, Olivier, J. Paul, Pecani, Kresti, Chait, Brian T., Aitchison, John D., Rout, Michael P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884143/ https://www.ncbi.nlm.nih.gov/pubmed/36720309 http://dx.doi.org/10.1016/j.jbc.2023.102954 |
Ejemplares similares
-
Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virus
por: Ketaren, Natalia E., et al.
Publicado: (2023) -
Abstract 2702: Highly synergistic combinations of nanobodies that target SARS-CoV-2 reduce viral load in hACE2 transgenic mice
por: Olivier, Paul, et al.
Publicado: (2023) -
Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2
por: Mast, Fred D., et al.
Publicado: (2021) -
A robust pipeline for rapid production of versatile nanobody repertoires
por: Fridy, Peter C., et al.
Publicado: (2014) -
Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape
por: Mast, Fred D, et al.
Publicado: (2021)